TickerFacts.

Burning Rock Biotech Ltd (BNR): Revenue

Annual figures by period end, from SEC filings.

539.57M CNY
Year ended 2025-12-31
-1.4%
3-year compound annual growth
+4.6%
5-year compound annual growth
563.24M CNY2018-12-31: 208.87M CNY2019-12-31: 381.68M CNY2020-12-31: 429.90M CNY2021-12-31: 507.86M CNY2022-12-31: 563.24M CNY2023-12-31: 537.43M CNY2024-12-31: 515.82M CNY2025-12-31: 539.57M CNY539.57M CNY
2018-12-31 Revenue (CNY) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31539.57M CNY+4.6%2026-04-28, From 2025-01-01
2024-12-31515.82M CNY-4.0%2026-04-28, From 2024-01-01
2023-12-31537.43M CNY-4.6%2026-04-28, From 2023-01-01
2022-12-31563.24M CNY+10.9%2025-04-29, From 2022-01-01
2021-12-31507.86M CNY+18.1%2024-04-29, From 2021-01-01
2020-12-31429.90M CNY+12.6%2023-04-20, From 2020-01-01
2019-12-31381.68M CNY+82.7%2022-04-29, From 2019-01-01
2018-12-31208.87M CNYn/a2021-03-23, From 2018-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31539.57M CNY+4.6%
Concord Medical Services Holdings Ltd (CCM)2025-12-31460.51M CNY+19.9%

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗